Pathway for the management of hyperglycemia in critical care units

Critical Pathways in Cardiology

Volumn 5, Issue 2, 2006, Pages 114-120

  Herzog, Eyal ^a   Aziz, Emad ^a   Croitor, Sherryl ^a   Frankenberger, Olivier ^a   Gurunathan, Rajan ^a   Albu, Jeanine ^a   Mezitis, Nicholas ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Critical pathway; Diabetes; Hyperglycemia; Insulin; Insulin infusion

Indexed keywords

CORTICOSTEROID; HYPERTENSIVE FACTOR; INSULIN; INSULIN ASPART; INSULIN GLARGINE; NOVOLOG MIX;

ARTICLE; CLINICAL PROTOCOL; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTENSIVE CARE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33749429590     PISSN: 1535282X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hpc.0000221570.29146.fc     Document Type: Article

References (12)

1. Talbot TR. Diabetes mellitus and cardiothoracic surgical site infections. Am J Infect Control. 2005;33:353-359.
2. American Diabetes Association. National diabetes fact sheet. Available at: http://www.diabetes-statistics/national-diabetes-fact-sheet.jsp. Accessed January 10, 2006.
3. Hogan P, Dall T, Nikolov P. Economic cost of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932.
4. American College of Endocrinology Position Statement on Inpatient Diabetes and Metabolic Control. Endocr Pract. 2005;10:78-82.
5. Capes SE, Hunt D, Malmberg K, Gertein HCL. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
6. Furnary AP, Zerr KJ, Grunkemeier GL, et al. Hyperglycemia: a predictor of mortality following CABG in diabetes. Circulation. 1999;100:I-591.
7. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infections in diabetes after open heart operations. Ann Thorac Surg. 1997;63:356-361.
8. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367.
9. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57-65.
10. Malmberg K; DIGAMI Study Group. Prospective randomized study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
11. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461-467.
12. Lien LF, Spratt SE, Woods Z, et al. Optimizing hospital use of intravenous insulin therapy: improved management of hyperglycemia and error with a new nomogram. Endocr Pract. 2005;11:240-253.